The tumor suppressors pRB and p53 as regulators of adipocyte differentiation and function
Authors:
- Søren FeddersenSFSøren Feddersen
- Lise MadsenLMLise Madsen
- Karsten KristiansenKKKarsten Kristiansen
- 18 December 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 13 (2) , 235-246
Abstract
The retinoblastoma protein (pRB) and p53 are crucial members of regulatory networks controlling the cell cycle and apoptosis, and a hallmark of virtually all cancers is dysregulation of expression or function of pRB or p53. Although they are best known for their role in cancer development, it is now evident that both are implicated in metabolism and cellular development. To review the role of pRB and p53 in adipocyte differentiation and function emphasizing that pRB and p53, via their effects on adipocyte development and function, play a role in the regulation of energy metabolism and homeostasis. pRB is required for adipose conversion and also involved in determining its mitochondrial capacity. p53 inhibits adipogenesis and results suggest that it is involved in maintaining function of adipose tissue.Keywords
This publication has 89 references indexed in Scilit:
- New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditureNature, 2008
- PRDM16 controls a brown fat/skeletal muscle switchNature, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Transcriptional Control of Brown Fat Determination by PRDM16Cell Metabolism, 2007
- Adipocytes as regulators of energy balance and glucose homeostasisNature, 2006
- Adipocyte differentiation from the inside outNature Reviews Molecular Cell Biology, 2006
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004
- Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γNature, 2004
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998